Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

Is Henry Schein Stock Underperforming the Nasdaq?

Henry Schein, Inc. (HSIC), headquartered in Melville, New York, provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics. Valued at $9 billion by market cap, the company provides shop supplies, as well as dental and medical solutions and services to improve operational success and clinical outcomes.

Companies worth $2 billion or more are generally described as “mid-cap stocks,” and HSIC fits right into that category with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical distribution industry. A 94-year leader in healthcare distribution, HSIC is known for quality and reliability. Its product mix spans exclusive deals and private-label consumables serving 1 million+ customers. Under its BOLD+1 plan, acquisitions expand its footprint in software, specialty, and services to fuel digital transformation and long-term growth.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.